Stock News

Walmart Earnings & the State of the Consumer

Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY

New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis

Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion

FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma

Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma

CORRECTED-UPDATE 3-US FDA approves expanded use of Bristol Myers' cancer cell therapy (May 15)

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

These Stocks Moved the Most Today: GameStop, AMC, Arm, Squarespace, Walgreens, Tesla, Intel, Apple, and More

One stock is dragging down the S&P 500's earnings growth

BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC

Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study

BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial

Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip

Is Bristol Myers' Dividend in Danger?

Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint

Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial

2 Beaten-Down Stocks to Buy and Hold for 10 Years

Q1 2024 Editas Medicine Inc Earnings Call

Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution

As seen on...